2024 Multiple Sclerosis Highlight
US$ 24.39
sglt2 or glp 1 Cardiorenal Protection: Potential of Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes | Diabetes Therapy SGLT2 inhibitors and GLP-1 receptor
Description
GLP 1 medications do far more than support weight loss
Results We screened 10,670 studies and ultimately identified 5 eligible studies, encompassing 719 patients
The use of GLP-1 analogs is growing rapidly in obese and overweight patients who need to control body weight.
What the GLP-1 class is, why it is prescription-only, how telehealth assessment works, and why eligibility is decided by a practitioner
Plus, how her diagnosis led to her weight loss and more.
Download the full case study to explore proven strategies for pharma-grade cold chain success.
